Diabetes Clinical Trials in Ohio

Showing 121-140 of 627 trials

Wound Assessment Using Spectral Imaging US

NCT05415683

During the observational, non-interventional study, at Baseline Study Visit (BSV) subjects will be screened and consented. Eligible subjects will undergo imaging with the DeepView device. Pre- and post-debridement images will be obtained (if debridement performed per SOC), as well as reviewing medical history and physical assessments. Additional Study Visits (SVs) will be performed when patient returns to the clinic for Routine Clinic Visit for up to 12 weeks or wound closure. During these visits DeepView imaging will occur pre- and post-debridement, and the status of the subject's treatment will be recorded.

DiabetesDiabetic FootDiabetic Foot Ulcer

SpectralMD400 participantsStarted Jun 2022

Encino, California, United States • Los Angeles, California, United States • Lake Success, New York, United States +8 more locations

COMPLETEDPhase 1/232 miles

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

NCT03163511

VC02-101 will evaluate an experimental cell replacement therapy intended to provide a functional cure to subjects with Type 1 Diabetes and Hypoglycemia Unawareness.

Type 1 Diabetes Mellitus With Hypoglycemia

ViaCyte49 participantsStarted Jul 2017

Duarte, California, United States • Irvine, California, United States • Sacramento, California, United States +7 more locations

PreviousPage 7 of 32Next

Wound Assessment Using Spectral Imaging US

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

Diabetes Trials in Other Cities

MIRACLE of LIFE Study

Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes Mellitus

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes

Dissemination of the Cardiovascular Risk Service

Embecta AID System in Adults With Type 2 Diabetes

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release

Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Other Conditions in Ohio